Prediction of Reactivation After Antivascular Endothelial Growth Factor Monotherapy for Retinopathy of Prematurity: Multimodal Machine Learning Model Study
Journal of Medical Internet Research · 2025
DOI: 10.2196/60367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Internet Research, 2025. Verfasst von Rong Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Machine Learning, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Retinopathy of prematurity (ROP) is the leading preventable cause of childhood blindness. A timely intravitreal injection of antivascular endothelial growth factor (anti-VEGF) is required to prevent retinal detachment with consequent vision impairment and loss. However, anti-VEGF has been reported to be associated with ROP reactivation. Therefore, an accurate prediction of reactivation after treatment is urgently needed.
Objective
To develop and validate prediction models for reactivation after anti-VEGF intravitreal injection in infants with ROP using multimodal machine learning algorithms.
Methods
Infants with ROP undergoing anti-VEGF treatment were recruited from 3 hospitals, and conventional machine learning, deep learning, and fusion models were constructed. The areas under the curve (AUCs), accuracy, sensitivity, and specificity were used to show the performances of the prediction models.
Results
A total of 239 cases with anti-VEGF treatment were recruited, including 90 (37.66%) with reactivation and 149 (62.34%) nonreactivation cases. The AUCs for the conventional machine learning model were 0.806 and 0.805 in the internal validation and test groups, respectively. The average AUC, sensitivity, and specificity in the test for the deep learning model were 0.787, 0.800, and 0.570, respectively. The specificity, AUC, and sensitivity for the fusion model were 0.686, 0.822, and 0.800 in a test, separately.
Conclusions
We constructed 3 prediction models for ROP reactivation. The fusion model achieved the best performance. Using this prediction model, we could optimize strategies for treating ROP in infants and develop better screening plans after treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- School of Information Engineering, Guangdong University of Technology, Guangzhou, China.
- Department of Pediatric Ophthalmology, Guangzhou Children's Hospital and Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
- Department of Ophthalmology, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Rong Wu, Yu Zhang, Peijie Huang, Yiying Xie, Jianxun Wang, Shuangyong Wang, Qiuxia Lin, Yichen Bai, Songfu Feng, Nian Cai, Xiaohe Lu
Zitieren
APA
Wu, R., Zhang, Y., Huang, P., Xie, Y., Wang, J., Wang, S., Lin, Q., Bai, Y., Feng, S., Cai, N., & Lu, X. (2025). Prediction of Reactivation After Antivascular Endothelial Growth Factor Monotherapy for Retinopathy of Prematurity: Multimodal Machine Learning Model Study. Journal of Medical Internet Research. https://doi.org/10.2196/60367
Vancouver
Wu R, Zhang Y, Huang P, Xie Y, Wang J, Wang S, et al. Prediction of Reactivation After Antivascular Endothelial Growth Factor Monotherapy for Retinopathy of Prematurity: Multimodal Machine Learning Model Study. Journal of Medical Internet Research. 2025. doi:10.2196/60367
BibTeX
@article{Wu2025,
author = {Wu, Rong and Zhang, Yu and Huang, Peijie and Xie, Yiying and Wang, Jianxun and Wang, Shuangyong and Lin, Qiuxia and Bai, Yichen and Feng, Songfu and Cai, Nian and Lu, Xiaohe},
title = {Prediction of Reactivation After Antivascular Endothelial Growth Factor Monotherapy for Retinopathy of Prematurity: Multimodal Machine Learning Model Study},
journal = {Journal of Medical Internet Research},
year = {2025},
doi = {10.2196/60367}
}
EUVIMED